Tick tock, slow the eGFR clock: managing kidney risk in people with T2D

Supported by AstraZeneca

This is a promotional symposium sponsored and organised by AstraZeneca intended for GB HCPs only.

AstraZeneca has provided sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.

Loading feed